Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Novartis
Fuji
Mallinckrodt
Baxter
Covington
Cantor Fitzgerald
Fish and Richardson
Healthtrust
Boehringer Ingelheim

Generated: October 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018458

« Back to Dashboard
NDA 018458 describes TALACEN, which is a drug marketed by Sanofi Aventis Us and is included in one NDA. Additional details are available on the TALACEN profile page.

The generic ingredient in TALACEN is acetaminophen; pentazocine hydrochloride. There are sixty-six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the acetaminophen; pentazocine hydrochloride profile page.

Summary for NDA: 018458

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength650MG;EQ 25MG BASE
Approval Date:Sep 23, 1982TE:RLD:No

Expired Orange Book Patents for NDA: 018458

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us
TALACEN
acetaminophen; pentazocine hydrochloride
TABLET;ORAL018458-001Sep 23, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
McKesson
Novartis
Express Scripts
Accenture
Moodys
McKinsey
Cipla
Johnson and Johnson
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot